# Heuron Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/heuron-co

- Industry: Healthcare IT
- Headquarters: Seoul, South Korea
- Website: www.iheuron.com
- Total disclosed funding: $15M
- Latest round: Series B (Jul 16, 2020)
- Investors on record: 7

## About

Based in Seoul, South Korea, and established in 2017, Heuron Co., Ltd. operates as a medical AI development company that provides treatment solutions for central nervous system disorders. The company's president and chief executive officer Donghoon Shin graduated from Ajou University College of Medicine. He is an associate professor at Gachon University Gil Medical Center. In February 2021, it obtained NET(New Excellent Technology) certification for Nigrosome biomarker discovery technology in MR imaging. In July 2020, it obtained MFDS (Class II) certification for Medical Image Analysis Device Software. The company has partnerships with Ajou University Hospital, Gangnam Severance Hospital, and Seoul St. Mary's Hospital.

The company has more than 20 clinical data-centered diagnostic programs under development for Parkinson's disease, dementia, stroke, and brain tumors?. The company has developed AI software enabling early diagnosis of degenerative diseases of the brain.

## Funding rounds

- Series B, Jul 16, 2020, $13M — Korea Investment & Securities, AJU IB Investment, HB Investment, JB Investment, K-Growth, Log Investment
- Series A, Jul 2, 2019, $2.6M — AJU IB Investment, Smilegate Investment, JB Investment

## Investors

- AJU IB Investment (https://capitalatlas.ai/funds/aju-ib-investment) — Series A, Series B
- Smilegate Investment (https://capitalatlas.ai/funds/smilegate-investment) — Series A
- JB Investment (https://capitalatlas.ai/funds/jb-investment) — Series A, Series B
- Korea Investment & Securities (https://capitalatlas.ai/funds/korea-investment-securities) — Series B
- HB Investment (https://capitalatlas.ai/funds/hb-investment) — Series B
- K-Growth (https://capitalatlas.ai/funds/k-growth) — Series B
- Log Investment (https://capitalatlas.ai/funds/log-investment) — Series B
